Drug News April 12, 2026
Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option
This article from Endpoints News covers: Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option.
Source: Endpoints News • Editorial summary by GLP-1 Price Guide
What This Means for You
This article from Endpoints News covers: Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option.
This article from Endpoints News covers: Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option.
Source: Endpoints News
Keep Reading
Original source
Read the full article at Endpoints News